Title:
LACTOBACILLUS PLANTARUM KBL396 STRAIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/151843
Kind Code:
A1
Abstract:
The present invention relates to a novel lactic acid bacteria strain Lactobacillus plantarum KBL396) KCTC13278BP, a composition comprising at least one selected from the group consisting of a culture of the strain, a lysate of the strain, and an extract of the strain, and a use thereof in foods and drugs. A strain and a composition according to the present invention exhibits excellent effects on the alleviation of neurological disorders, specially mental disorders and neurodegenerative disorders, and have no risks of side effects in the human body, thereby finding useful application in the alleviation of neurological disorder.
Inventors:
CHOI YONGBIN (KR)
KIM JISOO (KR)
LEE JUNE-CHUL (KR)
KO GWANG PYO (KR)
NAM TAE-WOOK (KR)
KIM JISOO (KR)
LEE JUNE-CHUL (KR)
KO GWANG PYO (KR)
NAM TAE-WOOK (KR)
Application Number:
PCT/KR2019/001525
Publication Date:
August 08, 2019
Filing Date:
February 07, 2019
Export Citation:
Assignee:
KO BIOLABS INC (KR)
International Classes:
C12N1/20; A23L33/135; A61K35/747; A61P25/00; C12R1/25
Foreign References:
KR101394348B1 | 2014-05-13 | |||
US20170312232A1 | 2017-11-02 | |||
EP2528610B1 | 2013-11-13 |
Other References:
DAVIS, D. J. ET AL.: "Lactobacillus plantarum attenuates anxiety-related behavior and protects against stress-induced dysbiosis in adult zebrafish", SCI. REP., vol. 6, 19 September 2016 (2016-09-19), pages 1 - 11, XP009511036
WALLACE, C. J. K. ET AL.: "The effects of probiotics on depressive symptoms in humans: a systematic review", ANN. GEN. PSYCHIATRY, vol. 16, no. 1, 20 February 2017 (2017-02-20), pages 1 - 10, XP055627980
SODHI MS ET AL., INT REV NEUROBIOL, vol. 59, 2004, pages 111 - 174
BECKER ET AL., DRUG DEVELOPMENT RESEARCH, vol. 12, 1988, pages 163 - 195
REPORT OF A JOINT FAO/WHO WORKING GROUP ON DRAFTING GUIDELINES FOR THE EVALUATION OF PROBIOTICS IN FOOD, 2002
L. LACHMAN ET AL.: "The Theory and Practice of Industrial Pharmacy", 1986, pages: 365 - 373
H. SUCKER ET AL.: "Pharmazeutische Technologie", 1991, THIEME, pages: 355 - 359
"Hagers Handbuchder pharmazeutischen Praxis", vol. 7, 1971, SPRINGERVERLAG, pages: 739 - 742,766-742
"Remington's Pharmaceutical Sciences", 1970, MACK PUBL., CO., pages: 1689 - 1691
SLYTER, L. L., J. ANIMAL SCI., vol. 43, 1976, pages 910 - 926
JOHNSON, D. E ET AL., J. ANIM. SCI., vol. 56, 1983, pages 735 - 739
See also references of EP 3747988A4
WALLACE, C. J. K. ET AL.: "The effects of probiotics on depressive symptoms in humans: a systematic review", ANN. GEN. PSYCHIATRY, vol. 16, no. 1, 20 February 2017 (2017-02-20), pages 1 - 10, XP055627980
SODHI MS ET AL., INT REV NEUROBIOL, vol. 59, 2004, pages 111 - 174
BECKER ET AL., DRUG DEVELOPMENT RESEARCH, vol. 12, 1988, pages 163 - 195
REPORT OF A JOINT FAO/WHO WORKING GROUP ON DRAFTING GUIDELINES FOR THE EVALUATION OF PROBIOTICS IN FOOD, 2002
L. LACHMAN ET AL.: "The Theory and Practice of Industrial Pharmacy", 1986, pages: 365 - 373
H. SUCKER ET AL.: "Pharmazeutische Technologie", 1991, THIEME, pages: 355 - 359
"Hagers Handbuchder pharmazeutischen Praxis", vol. 7, 1971, SPRINGERVERLAG, pages: 739 - 742,766-742
"Remington's Pharmaceutical Sciences", 1970, MACK PUBL., CO., pages: 1689 - 1691
SLYTER, L. L., J. ANIMAL SCI., vol. 43, 1976, pages 910 - 926
JOHNSON, D. E ET AL., J. ANIM. SCI., vol. 56, 1983, pages 735 - 739
See also references of EP 3747988A4
Attorney, Agent or Firm:
LEE, Cheo Young et al. (KR)
Download PDF: